| Quarterly Financials | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 196 | 215 | 202 | 196 | 204 | 204 | 210 | 205 | 225 | 239 | 232 | 251 |
| Expenses | 159 | 176 | 165 | 161 | 167 | 166 | 174 | 179 | 190 | 199 | 198 | 205 |
| EBITDA | 36 | 40 | 37 | 35 | 37 | 39 | 36 | 27 | 34 | 40 | 34 | 46 |
| Operating Profit % | 18 % | 18 % | 18 % | 18 % | 18 % | 19 % | 16 % | 13 % | 15 % | 16 % | 14 % | 19 % |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 8 | 8 | 8 | 8 | 8 |
| Interest | 4 | 5 | 3 | 4 | 5 | 5 | 5 | 8 | 9 | 10 | 8 | 9 |
| Profit Before Tax | 28 | 31 | 30 | 27 | 28 | 29 | 26 | 11 | 17 | 23 | 18 | 29 |
| Tax | 7 | 8 | 7 | 7 | 7 | 8 | 7 | 3 | 4 | 6 | 5 | 7 |
| Net Profit | 21 | 23 | 22 | 20 | 21 | 22 | 19 | 8 | 13 | 17 | 12 | 22 |
| EPS in ₹ | 2.13 | 2.39 | 2.23 | 2.00 | 2.08 | 2.17 | 1.93 | 0.77 | 1.30 | 1.68 | 1.24 | 2.18 |
Gufic BioSciences
Gufic BioSciences
333.85
+7.95
(2.44%)
Market Cap
3,347.90 Cr
PE Ratio
67.11
Volume
2,67,768.00
Day High - Low
341.95 - 319.65
52W High-Low
407.85 - 268.00
Key Fundamentals
Market Cap
3,347.90 Cr
EPS
6.95
PE Ratio
67.11
PB Ratio
5.32
Book Value
62.94
EBITDA
139.70
Dividend Yield
0.03 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
11.59
Debt to Equity
0.59
Actual
Company News
View All News
Gufic Biosciences posts Q4 FY26 results
2 days ago
2 days agoGufic Biosciences reported Q4 FY26 revenue of ₹252.1 crore and PAT of ₹20.5 crore. The Indore facility achieved 30% capacity utilization.
Gufic Biosciences re-appointed M/s. Poddar & Co. as Cost Auditor and appointed Mrs. Saroj R. Kirdolia as Internal Auditor for FY27.
Gufic Biosciences approved a ₹5.75 crore investment in Saraswat Co-operative Bank to strengthen banking ties. The subscription involves 57.50 lakh equity shares at face value.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,799.20 | #1 4,31,688.30 | 37.54 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 46.23 | |
6,667.00 | 1,76,987.90 | 68.85 | 10,560.00 | 8.73 | 2,520 | 13.44 | 50.98 | |
4,410.80 | 1,49,281.50 | 69.56 | 13,753.00 | 19.18 | 2,028 | -26.91 | 52.33 | |
1,401.00 | 1,13,170.10 | 29.25 | 27,711.70 | -2.46 | 3,783 | -55.32 | 59.75 | |
1,303.50 | 1,08,795.70 | 26.16 | 33,593.30 | -0.44 | 3,998 | -86.05 | 50.35 | |
1,077.70 | 1,08,441.80 | 21.16 | 26,719.70 | 13.65 | 5,242 | 7.82 | 72.44 | |
2,267.70 | 1,03,643.70 | #1 19.40 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 45.61 | |
2,375.60 | 98,066.00 | 50.66 | 14,277.60 | 12.03 | 1,750 | 31.75 | 50.18 | |
1,426.40 | 82,845.50 | 23.73 | 33,384.70 | 3.21 | 3,376 | 1.99 | 45.43 | |
1,362.00 | 73,528.50 | 82.57 | 6,812.90 | #1 21.03 | 884 | 21.18 | 73.71 |
Growth Rate
Revenue Growth
1.81 %
Net Income Growth
-19.16 %
Cash Flow Change
1,743.03 %
ROE
-28.32 %
ROCE
-16.55 %
EBITDA Margin (Avg.)
-7.27 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2024 | 2025 | 2026 |
| Total Assets | 1,093 | 1,169 | 1,342 |
| Fixed Assets | 159 | 506 | 513 |
| Current Assets | 601 | 625 | 802 |
| Capital Work in Progress | 307 | 22 | 22 |
| Investments | 2 | 2 | 325 |
| Other Assets | 625 | 640 | 0 |
| Total Equity & Liabilities | 1,093 | 1,169 | 1,342 |
| Current Liabilities | 372 | 388 | 518 |
| Non Current Liabilities | 188 | 181 | 160 |
| Total Equity | 533 | 601 | 665 |
| Reserve & Surplus | 523 | 591 | 655 |
| Share Capital | 10 | 10 | 10 |
Cash Flow
| Cash Flow | 2024 | 2025 |
| Net Cash Flow | -28 | 15 |
| Investing Activities | -102 | -71 |
| Operating Activities | -8 | 123 |
| Financing Activities | 82 | -37 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Oct 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 65.75 % | 65.13 % | 75.48 % | 75.48 % | 75.48 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 72.51 % | 72.51 % | 72.51 % | 72.51 % | 72.51 % | 72.51 % | 72.51 % | 72.51 % | 72.50 % | 72.50 % | 72.50 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.72 % | 0.00 % | 0.12 % | 0.23 % | 0.24 % | 0.30 % | 0.31 % | 0.32 % | 0.34 % | 0.44 % | 0.42 % |
| DIIs | 8.25 % | 3.24 % | 2.13 % | 1.19 % | 1.03 % | 1.03 % | 1.16 % | 1.16 % | 1.16 % | 1.16 % | 1.50 % | 1.58 % | 1.60 % | 2.20 % | 2.39 % | 2.51 % | 2.98 % | 3.39 % | 3.38 % | 3.65 % | 3.74 % | 3.83 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 21.92 % | 27.67 % | 17.00 % | 17.40 % | 17.65 % | 17.84 % | 18.29 % | 18.24 % | 17.83 % | 17.84 % | 17.16 % | 16.66 % | 16.85 % | 16.72 % | 16.36 % | 16.01 % | 15.44 % | 15.15 % | 15.10 % | 14.45 % | 14.13 % | 13.93 % |
| Others | 4.08 % | 3.95 % | 5.39 % | 5.94 % | 5.84 % | 6.13 % | 5.55 % | 5.60 % | 6.01 % | 6.00 % | 6.34 % | 8.53 % | 9.04 % | 8.45 % | 8.52 % | 8.73 % | 8.76 % | 8.64 % | 8.70 % | 9.06 % | 9.19 % | 9.31 % |
| No of Share Holders | 19,639 | 45,602 | 35,135 | 34,580 | 38,144 | 40,120 | 41,376 | 40,562 | 38,902 | 38,624 | 36,557 | 36,524 | 34,424 | 34,695 | 32,250 | 32,825 | 33,299 | 31,844 | 31,876 | 31,420 | 30,362 | 29,223 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.05 | 0.05 | 0.05 | 0.05 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.00 |
| Dividend Yield (%) | 0.05 | 0.07 | 0.1 | 0.04 | 0.04 | 0.05 | 0.04 | 0.03 | 0.04 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 14 Sept 2021 |  Dividend | ₹ 0.10 /share | 09 Sept 2021 | 189.20 | 197.80 |
| 25 Aug 2022 | Dividend | ₹ 0.10 /share | 24 Aug 2022 | 243.75 | 205.20 |
| 21 Sept 2023 | Dividend | ₹ 0.10 /share | 21 Sept 2023 | 207.55 | 285.35 |
| 29 Sept 2023 |  Annual General Meeting | NA | 29 Sept 2023 | 308.70 | 286.75 |
| 19 Sept 2024 | Dividend | ₹ 0.10 /share | 17 Sept 2024 | 312.15 | 397.60 |
| 25 Sept 2024 | Annual General Meeting | NA | 25 Sept 2024 | 393.65 | 389.90 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 473.55 | 437.50 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 426.15 | 406.00 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 380.45 | 390.90 |
| 13 Aug 2025 | Quarterly Result Announcement | NA | 13 Aug 2025 | 364.00 | 354.10 |
| 22 Sept 2025 | Dividend | ₹ 0.10 /share | 22 Sept 2025 | 390.90 | 369.45 |
| 29 Sept 2025 | Annual General Meeting | NA | 29 Sept 2025 | 369.85 | 358.00 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 328.15 | 325.90 |
| 13 Feb 2026 | Quarterly Result Announcement | NA | 13 Feb 2026 | 308.05 | 312.65 |
| 29 May 2026 | Quarterly Result Announcement | NA | 29 May 2026 | 288.70 | 325.90 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Investor Presentation2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Change in Management2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Acquisition2 days ago
2 days agoCorporate Action-Board approves Dividend2 days ago
2 days agoResults - Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31 20262 days ago
2 days agoBoard Meeting Outcome for Meeting Held On Friday May 29 20262 days ago
2 days agoCompliances-Reg.24(A)-Annual Secretarial Compliance4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation6 days ago
6 days agoBoard Meeting Intimation for Consideration And Approval Of Inter Alia Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Financial Year Ended March 31 2026 And To Recommend A Final Dividend If Any For The Financial 9 days ago
9 days agoUpdate On Further Investment In Selvax Pty Ltd.Apr 29, 2026
Apr 29, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 15, 2026
Apr 15, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Apr 07, 2026Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 03, 2026
Apr 03, 2026Closure of Trading WindowMar 27, 2026
Mar 27, 2026Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 13, 2026
Mar 13, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 24, 2026
Feb 24, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 20, 2026
Feb 20, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 16, 2026
Feb 16, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 14, 2026
Feb 14, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-AcquisitionFeb 13, 2026
Feb 13, 2026Results - Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2025Feb 13, 2026
Feb 13, 2026Board Meeting Outcome for For Meeting Held On Friday February 13 2026Feb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 10, 2026
Feb 10, 2026Board Meeting Intimation for Consideration And Approval Of Inter Alia Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2025Feb 09, 2026
Feb 09, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 04, 2026
Feb 04, 2026Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 20, 2026
Jan 20, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Closure of Trading WindowDec 30, 2025
Dec 30, 2025Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 27, 2025
Dec 27, 2025Intimation Of Environmental Social And Governance (ESG) RatingDec 10, 2025
Dec 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 21, 2025
Nov 21, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 21, 2025
Nov 21, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 17, 2025
Nov 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 17, 2025
Nov 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2025
Nov 15, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 14, 2025
Nov 14, 2025Results - Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2025Nov 14, 2025
Nov 14, 2025Board Meeting Outcome for Meeting Held On Friday November 14 2025Nov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Nov 11, 2025Announcement under Regulation 30 (LODR)-Credit RatingNov 10, 2025
Nov 10, 2025Board Meeting Intimation for Consideration And Approval Of Inter Alia Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended September 30 2025Nov 07, 2025
Nov 07, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 18, 2025
Oct 18, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Oct 07, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 30, 2025
Sep 30, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 24, 2025
Sep 24, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 18, 2025
Sep 18, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Motilal Oswal BSE 1000 Index Fund Direct-Growth | 0.00% | 3 | 0.00% | 0.00% | |
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.06% | 0 | 0.00% | 0.00% | |
 Bank of India Business Cycle Fund Direct-Growth | 0.89% | 0 | 0.00% | -0.09% | |
Bank of India Small Cap Fund Direct-Growth | 0.75% | 0 | 0.00% | -0.13% | |
 ICICI Prudential Bharat Consumption Fund Direct-Growth | 0.12% | 0 | 0.00% | 0.00% | |
ICICI Prudential ELSS Tax Saver Direct Plan-Growth | 0.02% | 0 | 0.00% | 0.00% | |
ICICI Prudential Multicap Fund Direct Plan-Growth | 0.25% | 0 | 0.00% | -0.03% | |
ICICI Prudential Smallcap Fund Direct Plan-Growth | 0.15% | 0 | 0.00% | -0.02% | |
Motilal Oswal Small Cap Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
 SBI Healthcare Opportunities Fund Direct Plan-Growth | 0.46% | 0 | 0.00% | -0.08% |
Technical Indicators
RSI(14)
Neutral 70.13
ATR(14)
Volatile 13.82
STOCH(9,6)
Neutral 74.39
STOCH RSI(14)
Overbought 92.75
MACD(12,26)
Bullish 5.01
ADX(14)
Strong Trend 26.06
UO(9)
Bearish 59.71
ROC(12)
Uptrend And Accelerating 12.62
WillR(14)
Overbought -11.77
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
